CYP2C19 GENOTYPE-GUIDED ESCALATION AND DE-ESCALATION SWITCHING OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN A REAL-WORLD SETTING.

著录项

• 来源
  《Clinical Pharmacology and Therapeutics》 |2019年第1期|共1页
• 作者

  Martin J.; Williams A. K.; Klein M. D.; Sriramoju V. B.; Madan S.; Rossi J. S.; Stouffer G. A.; Lee C. R.;

  展开▼
• 作者单位

  UNC Eshelman Sch Pharm Div Pharmacol &

  Expt Therapeut Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Pharmacol &

  Expt Therapeut Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Cardiol Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Cardiol Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Cardiol Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Cardiol Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Cardiol Chapel Hill NC USA;

  UNC Eshelman Sch Pharm Div Pharmacol &

  Expt Therapeut Chapel Hill NC USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 药理学;
• 关键词